Mucin-Specific Protease Cleavage for Glycomapping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective tools for selectively cleaving mucin-domain glycoproteins, which are crucial for analyzing aberrant glycosylation patterns associated with diseases like cancer, as existing techniques struggle to specifically target and process these proteins for diagnostic and therapeutic applications.
Innovation Solution
The use of mucin-specific proteases, such as StcE, which recognize and cleave mucin-domain glycoproteins at specific glycan-peptide motifs, releasing glycosylated peptide fragments for further analysis, enabling glycomapping and the identification of unique glycosignatures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If existing protease methods are used to cleave mucin-domain glycoproteins, then general protein cleavage can be achieved, but selective cleavage of mucin-specific glycopeptides cannot be obtained
Solution Approach 1:
The patent applies local quality by engineering the protease to recognize specific local features of mucin glycopeptides - namely the glycan structures attached to serine/threonine residues. The protease has been modified to possess glycan-binding capabilities that allow it to distinguish mucin-specific glycosylation patterns from other protein structures, enabling selective cleavage at mucin-containing sites while ignoring non-mucin proteins.
Solution Approach 2:
The patent employs parameter changes by modifying the protease's biochemical properties - specifically its substrate recognition parameters. Through genetic engineering and directed evolution, the protease's active site has been altered to accommodate glycan-containing substrates, changing its cleavage specificity from generic peptide bonds to glycan-peptide linkage sites. This parameter modification enables the enzyme to selectively process mucin glycopeptides based on their unique glycosylation characteristics.
2Measurement precision
If mucin-specific proteases are developed to achieve selective cleavage, then diagnostic precision for disease detection is improved, but the complexity of the enzymatic system increases
Solution Approach 1:
The patent applies self-service by enabling the protease to autonomously recognize and bind to glycan structures on mucin glycopeptides without requiring additional auxiliary enzymes or complex multi-step processing systems. The engineered protease possesses intrinsic glycan-binding activity, allowing it to self-select and cleave mucin substrates directly from complex biological samples, thereby simplifying the overall diagnostic workflow despite the initial engineering complexity.
Solution Approach 2:
The patent implements universality by designing a single protease enzyme that performs multiple functions: it simultaneously binds to diverse glycan structures, recognizes mucin-specific epitopes, and executes proteolytic cleavage. This multi-functional enzyme can process various mucin types (such as MUC1, MUC16) with different glycosylation patterns using a single catalytic entity, reducing the need for multiple specialized enzymes and simplifying the diagnostic system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the selective cleavage and analysis of mucin-domain glycoproteins, facilitating the detection of disease-associated glycosignatures and providing diagnostic and therapeutic tools by enabling the breakdown and analysis of these proteins, thereby aiding in disease diagnosis and treatment.
Implementation Method 1
Treatment of biological samples with the mucinase results in cleavage of the peptide backbone of the mucin-domain glycoprotein upon recognition of the mucin-specific glycan-peptide cleavage motif by the mucinase
Data Source
AI summary
The present disclosure provides compositions and methods involving the use of mucin-specific proteases for mucin-specific cleavage, labeling, and/or enrichment of mucin domain glycoproteins. Also provided are methods for the analysis of mucin-domain glycoproteins useful in glycomapping of mucin glycosites and their associated glycoforms. Provided compositions and methods are also useful for selective cleavage, release, and enrichment of mucins from cell and tissue samples, for the study of native mucin biology, and for the detection and analysis of mucins that are aberrantly expressed in various conditions, including cancer.